Cargando…

Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56(bright)CD16(+)NKp80(+/-) In-Vitro and Express KIR2DL2/DL3 and KIR3DL1

The differentiation of human induced pluripotent stem cells (hiPSCs) into T and natural killer (NK) lymphocytes opens novel possibilities for developmental studies of immune cells and in-vitro generation of cell therapy products. In particular, iPSC-derived NK cells gained interest in adoptive anti-...

Descripción completa

Detalles Bibliográficos
Autores principales: Euchner, Johanna, Sprissler, Jasmin, Cathomen, Toni, Fürst, Daniel, Schrezenmeier, Hubert, Debatin, Klaus-Michael, Schwarz, Klaus, Felgentreff, Kerstin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129508/
https://www.ncbi.nlm.nih.gov/pubmed/34017328
http://dx.doi.org/10.3389/fimmu.2021.640672
_version_ 1783694304123813888
author Euchner, Johanna
Sprissler, Jasmin
Cathomen, Toni
Fürst, Daniel
Schrezenmeier, Hubert
Debatin, Klaus-Michael
Schwarz, Klaus
Felgentreff, Kerstin
author_facet Euchner, Johanna
Sprissler, Jasmin
Cathomen, Toni
Fürst, Daniel
Schrezenmeier, Hubert
Debatin, Klaus-Michael
Schwarz, Klaus
Felgentreff, Kerstin
author_sort Euchner, Johanna
collection PubMed
description The differentiation of human induced pluripotent stem cells (hiPSCs) into T and natural killer (NK) lymphocytes opens novel possibilities for developmental studies of immune cells and in-vitro generation of cell therapy products. In particular, iPSC-derived NK cells gained interest in adoptive anti-cancer immunotherapies, since they enable generation of homogenous populations of NK cells with and without genetic engineering that can be grown at clinical scale. However, the phenotype of in-vitro generated NK cells is not well characterized. NK cells derive in the bone marrow and mature in secondary lymphoid tissues through distinct stages from CD56(bright)CD16(-) to CD56(dim)CD16(+) NK cells that represents the most abandoned population in peripheral blood. In this study, we efficiently generated CD56(+)CD16(+)CD3(-) NK lymphocytes from hiPSC and characterized NK-cell development by surface expression of NK-lineage markers. Hematopoietic priming of hiPSC resulted in 31.9% to 57.4% CD34(+)CD45(+) hematopoietic progenitor cells (HPC) that did not require enrichment for NK lymphocyte propagation. HPC were further differentiated into NK cells on OP9-DL1 feeder cells resulting in high purity of CD56(bright)CD16(-) and CD56(bright)CD16(+) NK cells. The output of generated NK cells increased up to 40% when OP9-DL1 feeder cells were inactivated with mitomycine C. CD7 expression could be detected from the first week of differentiation indicating priming towards the lymphoid lineage. CD56(bright)CD16(-/+) NK cells expressed high levels of DNAM-1, CD69, natural killer cell receptors NKG2A and NKG2D, and natural cytotoxicity receptors NKp46, NKp44, NKp30. Expression of NKp80 on 40% of NK cells, and a perforin(+) and granzyme B(+) phenotype confirmed differentiation up to stage 4b. Killer cell immunoglobulin-like receptor KIR2DL2/DL3 and KIR3DL1 were found on up to 3 and 10% of mature NK cells, respectively. NK cells were functional in terms of cytotoxicity, degranulation and antibody-dependent cell-mediated cytotoxicity.
format Online
Article
Text
id pubmed-8129508
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-81295082021-05-19 Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56(bright)CD16(+)NKp80(+/-) In-Vitro and Express KIR2DL2/DL3 and KIR3DL1 Euchner, Johanna Sprissler, Jasmin Cathomen, Toni Fürst, Daniel Schrezenmeier, Hubert Debatin, Klaus-Michael Schwarz, Klaus Felgentreff, Kerstin Front Immunol Immunology The differentiation of human induced pluripotent stem cells (hiPSCs) into T and natural killer (NK) lymphocytes opens novel possibilities for developmental studies of immune cells and in-vitro generation of cell therapy products. In particular, iPSC-derived NK cells gained interest in adoptive anti-cancer immunotherapies, since they enable generation of homogenous populations of NK cells with and without genetic engineering that can be grown at clinical scale. However, the phenotype of in-vitro generated NK cells is not well characterized. NK cells derive in the bone marrow and mature in secondary lymphoid tissues through distinct stages from CD56(bright)CD16(-) to CD56(dim)CD16(+) NK cells that represents the most abandoned population in peripheral blood. In this study, we efficiently generated CD56(+)CD16(+)CD3(-) NK lymphocytes from hiPSC and characterized NK-cell development by surface expression of NK-lineage markers. Hematopoietic priming of hiPSC resulted in 31.9% to 57.4% CD34(+)CD45(+) hematopoietic progenitor cells (HPC) that did not require enrichment for NK lymphocyte propagation. HPC were further differentiated into NK cells on OP9-DL1 feeder cells resulting in high purity of CD56(bright)CD16(-) and CD56(bright)CD16(+) NK cells. The output of generated NK cells increased up to 40% when OP9-DL1 feeder cells were inactivated with mitomycine C. CD7 expression could be detected from the first week of differentiation indicating priming towards the lymphoid lineage. CD56(bright)CD16(-/+) NK cells expressed high levels of DNAM-1, CD69, natural killer cell receptors NKG2A and NKG2D, and natural cytotoxicity receptors NKp46, NKp44, NKp30. Expression of NKp80 on 40% of NK cells, and a perforin(+) and granzyme B(+) phenotype confirmed differentiation up to stage 4b. Killer cell immunoglobulin-like receptor KIR2DL2/DL3 and KIR3DL1 were found on up to 3 and 10% of mature NK cells, respectively. NK cells were functional in terms of cytotoxicity, degranulation and antibody-dependent cell-mediated cytotoxicity. Frontiers Media S.A. 2021-05-04 /pmc/articles/PMC8129508/ /pubmed/34017328 http://dx.doi.org/10.3389/fimmu.2021.640672 Text en Copyright © 2021 Euchner, Sprissler, Cathomen, Fürst, Schrezenmeier, Debatin, Schwarz and Felgentreff https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Euchner, Johanna
Sprissler, Jasmin
Cathomen, Toni
Fürst, Daniel
Schrezenmeier, Hubert
Debatin, Klaus-Michael
Schwarz, Klaus
Felgentreff, Kerstin
Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56(bright)CD16(+)NKp80(+/-) In-Vitro and Express KIR2DL2/DL3 and KIR3DL1
title Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56(bright)CD16(+)NKp80(+/-) In-Vitro and Express KIR2DL2/DL3 and KIR3DL1
title_full Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56(bright)CD16(+)NKp80(+/-) In-Vitro and Express KIR2DL2/DL3 and KIR3DL1
title_fullStr Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56(bright)CD16(+)NKp80(+/-) In-Vitro and Express KIR2DL2/DL3 and KIR3DL1
title_full_unstemmed Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56(bright)CD16(+)NKp80(+/-) In-Vitro and Express KIR2DL2/DL3 and KIR3DL1
title_short Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56(bright)CD16(+)NKp80(+/-) In-Vitro and Express KIR2DL2/DL3 and KIR3DL1
title_sort natural killer cells generated from human induced pluripotent stem cells mature to cd56(bright)cd16(+)nkp80(+/-) in-vitro and express kir2dl2/dl3 and kir3dl1
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129508/
https://www.ncbi.nlm.nih.gov/pubmed/34017328
http://dx.doi.org/10.3389/fimmu.2021.640672
work_keys_str_mv AT euchnerjohanna naturalkillercellsgeneratedfromhumaninducedpluripotentstemcellsmaturetocd56brightcd16nkp80invitroandexpresskir2dl2dl3andkir3dl1
AT sprisslerjasmin naturalkillercellsgeneratedfromhumaninducedpluripotentstemcellsmaturetocd56brightcd16nkp80invitroandexpresskir2dl2dl3andkir3dl1
AT cathomentoni naturalkillercellsgeneratedfromhumaninducedpluripotentstemcellsmaturetocd56brightcd16nkp80invitroandexpresskir2dl2dl3andkir3dl1
AT furstdaniel naturalkillercellsgeneratedfromhumaninducedpluripotentstemcellsmaturetocd56brightcd16nkp80invitroandexpresskir2dl2dl3andkir3dl1
AT schrezenmeierhubert naturalkillercellsgeneratedfromhumaninducedpluripotentstemcellsmaturetocd56brightcd16nkp80invitroandexpresskir2dl2dl3andkir3dl1
AT debatinklausmichael naturalkillercellsgeneratedfromhumaninducedpluripotentstemcellsmaturetocd56brightcd16nkp80invitroandexpresskir2dl2dl3andkir3dl1
AT schwarzklaus naturalkillercellsgeneratedfromhumaninducedpluripotentstemcellsmaturetocd56brightcd16nkp80invitroandexpresskir2dl2dl3andkir3dl1
AT felgentreffkerstin naturalkillercellsgeneratedfromhumaninducedpluripotentstemcellsmaturetocd56brightcd16nkp80invitroandexpresskir2dl2dl3andkir3dl1